Chromothripsis: an emerging crossroad from aberrant mitosis to therapeutic opportunities
Journal of Molecular Cell Biology · 30.09.2024 · 16 (4)
DOI: 10.1093/jmcb/mjae016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Molecular Cell Biology, online erschienen am 06.05.2024. Verfasst von Umer Ejaz und 5 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory for Membraneless Organelles and Cellular Dynamics, University of Science and Technology of China School of Life Sciences, Hefei 23…. Hauptthemen laut MEDLINE: Chromothripsis, Mitosis, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, University of Science and Technology of China.
Abstract (Originalsprache)
Chromothripsis, a type of complex chromosomal rearrangement originally known as chromoanagenesis, has been a subject of extensive investigation due to its potential role in various diseases, particularly cancer. Chromothripsis involves the rapid acquisition of tens to hundreds of structural rearrangements within a short period, leading to complex alterations in one or a few chromosomes. This phenomenon is triggered by chromosome mis-segregation during mitosis. Errors in accurate chromosome segregation lead to formation of aberrant structural entities such as micronuclei or chromatin bridges. The association between chromothripsis and cancer has attracted significant interest, with potential implications for tumorigenesis and disease prognosis. This review aims to explore the intricate mechanisms and consequences of chromothripsis, with a specific focus on its association with mitotic perturbations. Herein, we discuss a comprehensive analysis of crucial molecular entities and pathways, exploring the intricate roles of the CIP2A–TOPBP1 complex, micronuclei formation, chromatin bridge processing, DNA damage repair, and mitotic checkpoints. Moreover, the review will highlight recent advancements in identifying potential therapeutic targets and the underlying molecular mechanisms associated with chromothripsis, paving the way for future therapeutic interventions in various diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory for Membraneless Organelles and Cellular Dynamics, University of Science and Technology of China School of Life Sciences, Hefei 230027, China.
- Anhui Key Laboratory for Chemical Biology, Hefei National Science Center for Inter-disciplinary Sciences, Hefei 230027, China.
- University of California San Diego School of Medicine, San Diego, CA 92103, USA.
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- University of Science and Technology of China
Zitieren
APA
Ejaz, U., Dou, Z., Yao, P. Y., Wang, Z., Liu, X., & Yao, X. (2024). Chromothripsis: an emerging crossroad from aberrant mitosis to therapeutic opportunities. Journal of Molecular Cell Biology, 16(4). https://doi.org/10.1093/jmcb/mjae016
Vancouver
Ejaz U, Dou Z, Yao PY, Wang Z, Liu X, Yao X. Chromothripsis: an emerging crossroad from aberrant mitosis to therapeutic opportunities. Journal of Molecular Cell Biology. 2024;16(4). doi:10.1093/jmcb/mjae016
BibTeX
@article{Ejaz2024,
author = {Ejaz, Umer and Dou, Zhen and Yao, Phil Y and Wang, Zhikai and Liu, Xing and Yao, Xuebiao},
title = {Chromothripsis: an emerging crossroad from aberrant mitosis to therapeutic opportunities},
journal = {Journal of Molecular Cell Biology},
year = {2024},
volume = {16},
number = {4},
doi = {10.1093/jmcb/mjae016}
}
EUVIMED